INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,000 | -86.7% | 994 | -91.1% | 0.00% | – |
Q3 2017 | $15,000 | -63.4% | 11,161 | -57.7% | 0.00% | – |
Q2 2017 | $41,000 | -51.8% | 26,396 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $85,000 | +150.0% | 26,396 | +5.9% | 0.00% | – |
Q4 2016 | $34,000 | +88.9% | 24,920 | +115.0% | 0.00% | – |
Q3 2016 | $18,000 | -69.5% | 11,591 | +3.5% | 0.00% | -100.0% |
Q1 2016 | $59,000 | -57.2% | 11,194 | -11.4% | 0.00% | 0.0% |
Q2 2015 | $138,000 | – | 12,635 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |